Stony Brook University Hospital, previously known as Stony Brook University Medical Center, is a nationally ranked, 695-bed non-profit, research, and academic medical center located in Stony Brook, New York, providing tertiary care for the entire Long Island region.

There are 695 beds in Stony Brook University Hospital.

During the past decade, Stony Brook University Hospital conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 28 clinical trials were completed, i.e. on average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 12 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stony Brook University Hospital" #1 sponsor was "Stony Brook University" with 32 trials, followed by "Biosite" with 3 trials sponsored, "Purdue Pharma LP" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "GPCR Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 69 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stony Brook University Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Medical University of South Carolina" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Stony Brook University Hospital" are "Heart Failure" (6 trials), "Atrial Fibrillation" (4 trials), "COVID-19" (4 trials), "Pain" (4 trials) and "COVID" (3 trials). Many other conditions were trialed in "Stony Brook University Hospital" in a lesser frequency.

Most popular intervention types in "Stony Brook University Hospital" are "Drug" (60 trials), "Device" (27 trials), "Biological" (11 trials), "Other" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Propofol" (3 trials), "Bevacizumab" (2 trials), "Chamomile Extract Capsule" (2 trials) and "Chamomile Tea" (2 trials). Other intervention names were less common.

The vast majority of trials in "Stony Brook University Hospital" are 108 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 36 active trials in "Stony Brook University Hospital". 1 are not yet recruiting, 25 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 52 completed trials in Stony Brook University Hospital, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Stony Brook University Hospital, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 26 trials that are defined as “Not Applicable".